Effects of plasma lipoproteins on the production of superoxide anion by human polymorphonuclear leukocytes in vitro

BioFactors

Volumn 6, Issue 2, 1997, Pages 157-163

  Couderc, Rémy ^a  

^a HÔPITAL TENON   (France)

Author keywords

Atherogenesis; Lipoproteins; Polymorphonuclear leukocyte; Superoxide

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; LOW DENSITY LIPOPROTEIN; MEMBRANE RECEPTOR; NIFLUMIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPASE D; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; STAUROSPORINE; SUPEROXIDE; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; CELL FUNCTION; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030713366     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520060209     Document Type: Article

References (6)

1. L.K. Curtiss, D.H. De Heer and T.S. Edgington, Influence of the immunoregulatory serum lipoprotein LDL-In on the in vivo proliferation and differentiation of antigen-binding and antibody-secreting lymphocytes during a primary immune response, Cell. Immunol. 49 (1980), 1-11.
2. L.K. Curtiss and T.S. Edgington, Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein, J. Immunol. 116(5) (1976), 1452-1458.
3. J. Hagmann, I. Weiler and E. Waelti, Effects of low density lipoproteins on lymphocyte stimulation, FEBS Lett. 97(2) (1979), 230-232.
4. J.L. Kelley, M.M. Rozek, C.A. Suenram and C.J. Schwartz, Activation of human peripheral blood monocytes by lipoproteins, Am. J. Pathol. 130(2) (1988), 223-231.
5. G. Paragh, J.T. Nagy, E. Szondy, G. Foris and A. Leovey, Immunomodulating effect of low density lipoprotein on human monocytes, Clin. Exp. Immunol. 64 (1986), 665-672.
6. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum, Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity, N. Engl. J. Med. 320(14) (1989), 915-924.